<DOC>
	<DOCNO>NCT01172743</DOCNO>
	<brief_summary>This protocol design gather small amount blood extraction DNA study genetic basis diabetes . The study population include individual know diabetes , control without diabetes . Investigators aim understand genetics diabetes , use cell serum blood perform genotyping gene expression study individual diabetes relevant control .</brief_summary>
	<brief_title>Collection Blood Gene Expression/Genomic Studies Individuals With Diabetes ( Qatar )</brief_title>
	<detailed_description>This protocol design collect small amount blood extraction DNA ( genetic material ) study genetic basis diabetes . The study population include individual know diabetes control without diabetes . Additionally , protocol recruit individual follow location : Qatar Diabetes Association , governmental ministry Qatar , subject participated Dr. Bener 's HMC protocol # 231 entitle `` A preliminary study genetic pre-disposition diabetic mellitus state Qatar . '' Individuals diabetes may also recruit Hamad Hospital outpatient adult diabetes clinic ( eight diabetes clinic week ) and/or population subject previously participate Dr. Mushlin 's IRB approve protocol # 0608008703 entitle `` Comparing Clinical Management Genetic Markers Diabetes Qatar International Standards '' Hamad Medical Corporation IRB approve protocol # 0602008388 entitle `` The Impact Cardiac Genetic Risk Factors Acute Myocardial Infarction Cerebrovascular Stroke Qatar : A Case-Control Study '' . In protocol , researcher survey medical record patient diabetes , order study clinical characteristic individual , researcher collect blood evaluate genetic characteristic individual diabetes . The researcher also collect blood sample individual without diabetes serve control .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Diabetes group Inclusion criterion : Must provide informed consent Males female , age 18 year old Documented evidence diabetes use least one following : ( 1 ) blood test consistent TypeII diabetes ; ( 2 ) oral glucose tolerance test consistent TypeII diabetes ; ( 3 ) subject take medication treat TypeII diabetes . Exclusion criterion : Individual refuse consent Pregnant females gestational diabetes TypeI diabetes Normal control group Must provide inform consent Males females age 18 year old Resolved gestational diabetes Individual refuse consent . Individuals history diabetes .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Type-2</keyword>
	<keyword>Adult Onset</keyword>
</DOC>